What are the definitions of denervation and reinnervation in a patient with an EMG demonstrating S1 radiculopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Denervation and Reinnervation in S1 Radiculopathy

Denervation refers to the loss of nerve supply to muscle fibers following axonal injury, characterized on EMG by spontaneous activity including fibrillation potentials and positive sharp waves, while reinnervation is the process where intact neighboring axons sprout to reconnect with denervated muscle fibers, producing polyphasic motor unit action potentials with increased duration and complexity.

Denervation: The Acute Injury Phase

When an axon is damaged in S1 radiculopathy, the muscle fibers lose their nerve supply and undergo denervation 1. This process follows a predictable timeline:

  • Immediate phase: Initially, spontaneous discharges only occur when muscle fibers are directly stimulated by needle movement during EMG
  • After ~1 week: Spontaneous activity develops with positive sharp waves and fibrillation potentials appearing on EMG 1
  • EMG characteristics: These are short duration muscle fiber action potentials (typically <5 ms duration) with regular discharge patterns and peak-to-peak amplitudes around 200 microvolts 1

Key EMG Findings in Denervation

The hallmark features include 1:

  • Fibrillation potentials: Spontaneously discharging individual muscle fibers
  • Positive sharp waves: Spontaneous short duration potentials always in the positive (downward) direction
  • Prolonged insertional activity: Activity extending beyond the normal 300 ms after needle movement
  • Both patterns discharge regularly and indicate active denervation

Reinnervation: The Recovery Phase

Over weeks to months following the initial injury, intact neighboring axons may sprout to reinnervate adjacent denervated muscle fibers 1. This represents the body's attempt to restore function:

Mechanism of Reinnervation

  • Axonal sprouting: Intact motor neurons send out new branches to reconnect with orphaned muscle fibers
  • Slower conduction: Because these axonal sprouts are thin and poorly myelinated, their conduction velocity is slower than original axonal branches 1
  • Asynchronous activation: The slower conduction results in muscle fibers within the same motor unit firing out of sync

EMG Characteristics of Reinnervation

The reinnervation process produces distinctive changes 1:

  • Polyphasic motor unit action potentials (MUAPs): Complex waveforms with at least four zero crossings producing five phases
  • Increased MUAP duration: Longer than normal due to asynchronous muscle fiber activation
  • Increased MUAP amplitude: Generally produces long duration, large amplitude MUAPs in neuropathic conditions 1
  • More complex waveforms: Multiple baseline crossings that must reappear consistently to distinguish from chance simultaneous firing 1

Clinical Context in S1 Radiculopathy

In a patient with S1 radiculopathy confirmed by EMG 2:

  • Muscles examined: Gastrocnemius (medial and lateral heads), biceps femoris (both heads are exclusively S1 innervated), and other S1 myotome muscles
  • Active denervation indicates ongoing nerve injury with fibrillations and positive waves
  • Chronic denervation-reinnervation shows polyphasic potentials indicating the nerve has been injured but recovery processes are underway 3, 4

Important Clinical Caveat

The presence of reinnervation does not necessarily indicate clinical improvement 5. Denervation and reinnervation comprise a dynamic process that can occur simultaneously in progressive conditions. The finding of reinnervation on EMG simply confirms that the injury occurred weeks to months prior and that collateral sprouting has begun—it does not predict functional recovery or indicate that the pathologic process has resolved.

Correlation with Imaging

MRI using STIR sequences shows increased signal intensity that corresponds closely with spontaneous activity on EMG in denervated muscle, with 84% sensitivity and 100% specificity 6. However, EMG remains more sensitive for detecting active denervation.

References

Guideline

recommendations of the neurolaryngology study group on laryngeal electromyography.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009

Research

Pain and calf hypertrophy associated with spontaneous repetitive discharges treated with botulinum toxin.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2005

Research

Muscle hypertrophy after partial denervation: a human case.

Journal of neurology, neurosurgery, and psychiatry, 1978

Related Questions

What are the clinical signs of S1 radiculopathy?
In a patient with lower extremity electromyography (EMG) indicating S1 radiculopathy, how likely is the radiculopathy to resolve such that a repeat EMG performed 1–2 years later will be normal?
In a patient with S1 radiculopathy, can a mechanical neuropathy develop and what clinical manifestations would it produce?
Can L5 radiculopathy present without pain?
I have had lower back pain for over one month radiating to my thighs and hamstrings, with knee skin discoloration and progressive lower extremity weakness; what is the likely diagnosis and what work‑up and management should be pursued?
In a patient with decompensated cirrhosis (Child‑Pugh B or C), should the metronidazole dose be reduced from 500 mg intravenous twice daily to 500 mg intravenous once daily?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, creatinine 1.18 mg/dL (eGFR ≈ 77 mL/min) on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, insulin sensitivity factor 50 mg/dL per unit, with capillary glucose 263 mg/dL at 1700 h, 231 mg/dL at 0200 h, and 284 mg/dL at 0700 h after meals of 80 g, 82 g, and 34 g carbohydrates, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, impaired renal function (creatinine 1.18 mg/dL, eGFR ≈ 77 mL/min) who is on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, and insulin‑sensitivity factor 50 mg/dL per unit, is it appropriate to increase basal Lantus to 15 U, adjust the insulin‑sensitivity factor to 25 mg/dL per unit, and set the insulin‑to‑carbohydrate ratio to 1 U per 8 g carbohydrate?
Which infections and medications can trigger the development of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a 35-year-old male?
Are there different repetitive transcranial magnetic stimulation (rTMS) protocols for major depressive disorder and obsessive‑compulsive disorder?
Why is it important to inquire about vomiting and nausea in a patient with chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.